Cryoport
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 3 days.
- Recent price momentum is +70.8% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 6.9% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and above its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 02:27 UTC
Data coverage: 4 of 6 factors. Missing data is not a zero score.
The radar needs all six factors. Available grades are shown below.
Valuation N/A
How expensive the stock is versus earnings, sales and its own 5-year history.
Not enough data to grade this factor.
Growth N/A
How fast revenue, profit and free cash flow are compounding.
Not enough data to grade this factor.
Profitability B
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 47.1% | Better than 59% |
| Operating margin | -20.9% | Better than 12% |
| Net margin | 39.9% | Better than 95% |
| Return on equity | 17.0% | Better than 73% |
| Return on invested capital | 11.0% | Better than 72% |
Momentum A+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | 11.2% | Better than 91% |
| 6-month return | 36.1% | Better than 92% |
| 12-month return (ex latest month) | 104.8% | Better than 95% |
| Distance below 52-week high | 12.5% | Better than 77% |
Financial Health C-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 2.2x | Better than 60% |
| Debt to assets | 30.2% | Better than 41% |
| Interest coverage | -12.6x | Better than 12% |
Analyst View B-
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 100.0% | Better than 77% |
| Upside to average target | 13.4% | Better than 19% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 19.55
- Open
- 19.17
- Day range
- 18.83 - 19.45
- Avg price
- 19.05
- Volume
- 814.78K
- Turnover
- 15.52M
- Turnover ratei
- 1.67%
- Volume ratioi
- 1.28
- Amplitudei
- 3.17%
- 52-week rangei
- 7.61 - 21.78
Valuation
- P/Ei
- 13.61
- P/E (TTM)i
- -19.24
- P/Bi
- 2.22
- EPSi
- 1.40
- Book value / shi
- 8.59
- Net profit
- 70.98M
- Net assets
- 435.26M
Share structure
- Market cap
- 965.84M
- Float capi
- 932.12M
- Shares out
- 50.70M
- Float sharesi
- 48.93M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2015-04-23
12.5% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+1.38M net over the window
Short interest
- Shares short
- 3.48M
- % of floati
- 6.87%
- Days to coveri
- 4.14
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Cryoport (CYRX)?
Cryoport last traded at 19.05. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Cryoport's market cap?
About 965.84M.
What is the P/E ratio of Cryoport?
The trailing twelve-month P/E is -19.24. The Valuation tab shows it against the stock's own five-year range.
Does Cryoport pay a dividend?
Cryoport does not currently pay a regular dividend.
Is Cryoport a buy according to analysts?
The consensus of 5 analysts is a Buy rating, with an average 12-month price target of 21.60, which implies 13.4% upside from the current price. This is not investment advice.
What is Cryoport's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Cryoport a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Cryoport discussion 0 comments